DOCSLIB.ORG

Chemicals, Inc. New Products Introduced Since Catalog 24 an Employee-Owned Company

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chemicals, Inc. New Products Introduced Since Catalog 24 an Employee-Owned Company Chemicals, Inc. New Products Introduced Since Catalog 24 an employee-owned company metals · inorganics · organometallics · catalysts · ligands · custom synthesis · cGMP facilities · nanomaterials BARIUM (Compounds) $ Price 56-8120 Barium trifluoromethanesulfonimide, min. 97% [168106-22-7] 250mg 29.00 Ba(C F NO S ) ; FW: 697.62; white to off-white pwdr. 1g 99.00 2 6 4 2 2 HAZ hygroscopic 5g 415.00 BORON (Compounds) $ Price 96-0350 Biological Hydrogen Peroxide Imaging Kit (FBBBE, CBBE) $ 160 Note: Sold under license from The Reagents of the University of California. US Patent application 61/762,706. Contains the following: 05-0054 7-{[(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]oxy}-2H-1-benzopyran-2-one CBBE 3 x 5mg 05-0058 3',6'-Bis{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxy]-3H-[spiro(isobenzofuran-1,9,-xanthen]-3-one} FBBBE 3 x 5mg 97-4940 Dimethylsulfoxide (ACS spectrophotometric grade) 6 x 1.0 ml 05-0058 3',6'-Bis{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxy]- O 5mg 60.00 3H-[spiro(isobenzofuran-1,9,-xanthen]-3-one} FBBBE C46H46B2O9; FW: 764.47; faint yellow pwdr. O Note: Sold under license from The Reagents of the University of California. US Patent application 61/762,706. Biological Hydrogen Peroxide Imaging Kit O O O (FBBBE, CBBE) component. O O B B H3C CH3 O O H3C CH3 H3C CH3 CH CH3 3 05-1035 Tetrakis(dimethylamino)diboron [1630-79-1] 1g 78.00 C H B N ; FW: 197.93; colorless liq.; b.p. 55-57° (2.5mm); f.p. 99°C; d. 0.926 5g 312.00 8 24 2 4 moisture sensitive 05-0054 7-{[(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) 5mg 60.00 benzyl]oxy}-2H-1-benzopyran-2-one CBBE C2H23BO5; FW: 138.01; white pwdr. O O O Note: Sold under license from The Reagents of the O University of California. US Patent application B CH3 61/762,706. Biological Hydrogen Peroxide O CH3 Imaging Kit (FBBBE, CBBE) component. CH3 CH3 BISMUTH (Compounds) $ Price 83-2415 Bismuth(III) 2-ethylhexanoate, ~30% wt/wt Bi in 2-ethylhexanoic acid (99.98%-Bi) [67874-71-9] 50g 71.00 Bi[OOCCH(C2H5)C4H9]3; FW: 638.61; liq. 250g 284.00 BORON (Compounds) $ Price 05-1015 Tetrahydroxydiboron, min. 95% [13675-18-8] HO OH 1g 22.00 (OH)2BB(OH)2; FW: 89.65; white solid moisture sensitive 5g 49.00 BB 25g 196.00 Technical Notes: HO OH 1. Reagent used for the palladium-catalyzed aryl borylation of aryl halides 2. Reagent used for the copper-catalyzed β-boration of α,β-unsaturated carbonyl compounds. OH X BF K (OH) BB(OH) B KHF 3 2 2 OH 2 Tech. Note (1) 0.5% Pd(0) Ref. (1) R EtOH R R X = Br, Cl, I, OTf O 1) CyJOhnPhos (2 mol%) O BF K 3 CuCl (2 mol%). NaO-t-Bu (30 mol%) B2(OH)4 (1.2 equiv.), EtOH, rt 1 3 1 3 N 2R R N 2R R Tech. Note (1) 2) KHF 2, MeOH, H2O Ref. (2) R2 R2 References: 1. J. Am. Chem. Soc., 2012, 134, 11667. 2. Org. Lett., 2011,13, 4684. Visit www.strem.com for new product announcements. 7 Mulliken Way, Newburyport, MA 01950-4098 Tel.: (978) 499-1600 ● Fax: (978) 465-3104 ● Toll Free: (800) 647-8736 ● Fax: (800) 517-8736 Email: [email protected] ● [email protected] ● [email protected] ● [email protected] ● (All other inquiries) [email protected] NpsinceCat24_071714 -2- CADMIUM (Compounds) $ Price 48-1053 Cadmium selenide/cadmium sulfide CANdot® quantum rod (CdSe/CdS elongated .5ml 72.00 core/shell), 5 mg/ml in hexane, 560nm peak emission [1306-24-7] 2ml 216.00 HAZ CdSe/CdS; (store cold) Note: Sold in collaboration with CAN for research purposes. Technical Note: Stability: Store at 2-8°C in dark under inert atmosphere. Do not freeze. Safety: Hazardous - an additional Dangerous Goods freight charge may apply. 48-1056 Cadmium selenide/cadmium sulfide CANdot® quantum rod (CdSe/CdS elongated .5ml 72.00 core/shell), 5 mg/ml in hexane, 590nm peak emission [1306-24-7] 2ml 216.00 HAZ CdSe/CdS; (store cold) Note: Sold in collaboration with CAN for research purposes. Technical Note: Stability: Store at 2-8°C in dark under inert atmosphere. Do not freeze. Safety: Hazardous - an additional Dangerous Goods freight charge may apply. ® 48-1059 Cadmium selenide/cadmium sulfide CANdot quantum rod (CdSe/CdS elongated .5ml 72.00 core/shell), 5 mg/ml in hexane, 620nm peak emission [1306-24-7] 2ml 216.00 CdSe/CdS; (store cold) HAZ Note: Sold in collaboration with CAN for research purposes. Technical Note: Stability: Store at 2-8°C in dark under inert atmosphere. Do not freeze. Safety: Hazardous - an additional Dangerous Goods freight charge may apply. CALCIUM (Compounds) $ Price 20-5025 Calcium trifluoromethanesulfonimide, min. 97% [165324-09-4] 250mg 29.00 Ca(C2F6NO4S2)2; FW: 600.37; white solid 1g 99.00 hygroscopic 5g 415.00 COPPER (Compounds) $ Price 29-7120 Bis(dimethylamino-2-propoxy)copper(II), min. 98% Cu(dmap)2 250mg 60.00 [185827-91-2] 1g 180.00 Cu(C5H12NO)2; FW: 267.86; purple xtl. N Cu N air sensitive, hygroscopic O O 29-0550 Bis(N,N'-dimethylpiperazine)tetra[copper(I) iodide] [1401708-91-5] 500mg 38.00 (CuI) (C H N ) ; FW: 990.18; white pwdr. 2g 76.00 4 6 14 2 2 moisture sensitive, (store cold) 29-0565 (Hexamethylenetetramine)penta[copper(I) cyanide] [1042093-98-0] 500mg 38.00 C H (CuCN) ; FW: 588.00; white pwdr. 2g 76.00 6 12 5 hygroscopic, (store cold) 29-6720 Trifluoromethyl(1,10-phenanthroline)copper(I), 95% 250mg 85.00 ® Trifluoromethylator [1300746-79-5] 1g 285.00 (C H N )CuCF ; FW: 312.76; orange solid 5g 1282.00 12 8 2 3 air sensitive N N Note: Sold in collaboration with CATYLIX for research purposes only. Cu CF3 CYLINDERS & ADAPTERS (Other) $ Price 96-1075 Swagelok® Cylinder Assembly, 50ml with ” VCR Male Ball Valve and Female Nut, 1cyl 700.00 electropolished for CVD/ALD 96-1076 Swagelok® Cylinder Assembly, 50ml with ” VCR Male Bellows-Sealed Valve 1cyl 900.00 (High Temp) and Female Nut, electropolished for CVD/ALD 96-1078 Swagelok ¼" VCR Male DP high pressure diaphram Valve (High Purity), PCTFE seat, 1cyl 850.00 VCR Metal Gasket Seal Fitting, Round Handle (EP USE) GOLD (Compounds) $ Price 79-0125 Bis{1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2- 100mg 60.00 ylidene}-u-hydroxydigold(I), 99% [1262545-44-7] 500mg 240.00 C54H73Au2N4O; FW: 1188.12; white solid H Technical Note: N O N 1. Catalyst used in a Meyer-Schuster rearrangement reaction. Au Au O N N OH Au catalyst (2 mol%) Tech. Note (1) Ph MeOH/H2O 10:1 Ph Bu Ref. (1) RT 99% Bu Reference: 1. Organometallics, 2010, 29, 3665. Visit www.strem.com for new product announcements. 7 Mulliken Way, Newburyport, MA 01950-4098 Tel.: (978) 499-1600 ● Fax: (978) 465-3104 ● Toll Free: (800) 647-8736 ● Fax: (800) 517-8736 Email: [email protected] ● [email protected] ● [email protected] ● [email protected] ● (All other inquiries) [email protected] NpsinceCat24_071714 -3- GOLD (Compounds) $ Price 79-0230 Bis(trifluoromethanesulfonyl)imide(2-dicyclohexylphosphino- 100mg 48.00 2',6'-dimethoxy-1,1'-biphenyl)gold(I), 98% [1121960-90-4] 500mg 192.00 C28H35AuF6NO6PS2; FW: 887.64; white to off-white solid Cy SO2CF3 Technical Notes: P Au SO CF 1. Highly-efficient and regio-selective catalyst for the selective carbonyl migration in Cy 2 3 alkynyl-substituted indole-3-carboxamides. MeO OMe 2. Catalyst used in the hydroarylating/aromatization of arene-diynes. 3. Catalyst used in the selective hydration of substituted alkynes at room temperatures. O Ar N Ar C C C N SPhos-AuNTf2 Tech. Note (1) Ref. (1) air, toluene, 80°C N N O R R 5 mol% IPrAuR or basic additive Tech. Note (2) 15 mol% 2.5 mol% Ref. (2) IPrAuNTf2 IPrAuNTf2 + 80°C 80°C O AuPR NTF (0.5 - 5 mol%) 3 2 Tech. Note (3) XC C Y C Y Ref. (3) MeOH, H2O, r.t. X References: 1. Organometallics, 2005, 24, 5221. 65-100% 2. Adv. Synth. Catal., 2012, 354(7), 1273. 3. J. Org. Chem., 2009, 74, 2067. 79-0225 Chloro(2-dicyclohexylphosphino-2',6'-dimethoxy- 250mg 90.00 1,1'-biphenyl)gold(I), 98% [854045-95-7] 1g 270.00 Cy C26H35AuClO2P; FW: 642.95; white pwdr. P Au Cl Cy MeO OMe Technical Note: 1. See 79-0230. 79-0343 Chloro[2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino) 250mg 48.00 biphenyl]gold(I), 98% [1196707-11-5] 1g 144.00 C26H36AuClNP; FW: 625.96; white pwdr. P Au Cl H3C N Technical Note: H C 1. See 79-0348. 3 79-0352 2-(Di-t-butylphosphino)biphenyl(acetonitrile)gold(I) 250mg 97.00 hexafluoroantimonate, 99% [866641-66-9] 1g 291.00 C22H30F6AuNPSb; FW: 772.17; white to off-white pwdr. t-Bu air sensitive, moisture sensitive P + - Au SbF6 Technical Notes: t-Bu N 1. Gold catalyst used in the regio-and stereoselective synthesis of functionalized C benzo[b]oxepines.. CH3 2. Gold catalyst used in the cyclization reactions of o-(buta-1,3-diyn-1-yl-)-substituted N-aryl ureas. 3. Gold catalyst used in the cycloisomerization of 1,7-enyne esters to structurally diverse cis-1,2,3,6-tetrahydropyridin-4-yl ketones. 4. Catalyst used in the synthesis of coumarin-containing natural products.
Load more

Recommended publications
  • Article Download
    wjpls, 2018, Vol. 4, Issue 8, 153-159 Research Article ISSN 2454-2229 Sathyamurthy et al. World Journal of Pharmaceutical World Journal and Lifeof Pharmaceutical Sciences and Life Sciences WJPLS www.wjpls.org SJIF Impact Factor: 5.088 GCMS AND FTIR ANALYSIS ON THE METHANOLIC EXTRACT OF RED VITIS VINIFERA PULP 1Naresh S., 1Sunil K. S., 1Akki Suma, 1Ashika B. D., 1Chitrali Laha Roy, *2Dr. Balasubramanian Sathyamurthy 1Department of Biochemistry, Ramaiah College of Arts, Science and Commerce, Bangalore – 560054. *2Professor, Department of Biochemistry, Ramaiah College of Arts, Science and Commerce, Bangalore – 560054. *Corresponding Author: Dr. Balasubramanian Sathyamurthy Department of Biochemistry, Ramaiah College of Arts, Science and Commerce, Bangalore – 560054. Article Received on 12/06/2018 Article Revised on 02/07/2018 Article Accepted on 23/07/2018 ABSTRACT Red Vitis Vinifera pulp has major components such as Organic acids, Malate, Tartrate and Sugars and contains higher moisture content. Our work is designed to identify the possible phytochemicals compounds present in the methanolic extract of red grape pulp by using GCMS along with functional group analysis through FTIR. From the GCMS analysis of red Vitis Vinifera pulp nearly 61 compounds were identified. By FTIR analysis, strong absorption band was found at 3400 cm–1, which represents the amine groups and ketones at a frequency of –1 1066.02 cm gave maximum peaks. Hence, we can conclude that the red Vitis Vinifera pulp extract is rich in amines, ether and ester groups. KEYWORDS: GCMS, FTIR, spectral analysis, NIST. 1. INTRODUCTION biochemical and organic mixtures and it is also highly compatible.[4] Infrared spectroscopy is most powerful Red Grapes or Vitis vinifera is a Berry fruit and belongs technique for materials analysis and used in the to the group of versatile fruits which are used in a wide laboratories.
    [Show full text]
  • 624 — 632 [1974] ; Received January 9, 1974)
    Some ab Initio Calculations on Indole, Isoindole, Benzofuran, and Isobenzofuran J. Koller and A. Ažman Chemical Institute “Boris Kidric” and Department of Chemistry, University of Ljubljana, P.O.B. 537, 61001 Ljubljana, Slovenia, Yugoslavia N. Trinajstić Institute “Rugjer Boskovic”, Zagreb, Croatia, Yugoslavia (Z. Naturforsch. 29 a. 624 — 632 [1974] ; received January 9, 1974) Ab initio calculations in the framework of the methodology of Pople et al. have been performed on indole, isoindole, benzofuran. and isobenzofuran. Several molecular properties (dipole moments, n. m. r. chemical shifts, stabilities, and reactivities) correlate well with calculated indices (charge densities, HOMO-LUMO separation). The calculations failed to give magnitudes of first ionization potentials, although the correct trends are reproduced, i. e. giving higher values to more stable iso­ mers. Some of the obtained results (charge densities, dipole moments) parallel CNDO/2 values. Introduction as positional isomers 4 because they formally differ Indole (1), benzofuran (3) and their isoconju­ only in the position of a heteroatom. Their atomic gated isomers: isoindole (2) and isobenzofuran (4) skeletal structures and a numbering of atoms are are interesting heteroaromatic molecules1-3 denoted given in Figure 1. 13 1 HtKr^nL J J L / t hü H 15 U (3) U) Fig. 1. Atomic skeletal structures and numbering of atoms for indole (1), isoindole (2), benzofuran (3), and isobenzofuran (4). Reprint requests to Prof. Dr. N. Trinajstic, Rudjer Boskovic Institute, P.O.B. 1016, 41001 Zagreb I Croatia, Yugoslavia. Dieses Werk wurde im Jahr 2013 vom Verlag Zeitschrift für Naturforschung This work has been digitalized and published in 2013 by Verlag Zeitschrift in Zusammenarbeit mit der Max-Planck-Gesellschaft zur Förderung der für Naturforschung in cooperation with the Max Planck Society for the Wissenschaften e.V.
    [Show full text]
  • 20210311 IAEG AD-DSL V5.0 for Pdf.Xlsx
    IAEGTM AD-DSL Release Version 4.1 12-30-2020 Authority: IAEG Identity: AD-DSL Version number: 4.1 Issue Date: 2020-12-30 Key Yellow shading indicates AD-DSL family group entries, which can be expanded to display a non-exhaustive list of secondary CAS numbers belonging to the family group Substance Identification Change Log IAEG Regulatory Date First Parent Group IAEG ID CAS EC Name Synonyms Revision Date ECHA ID Entry Type Criteria Added IAEG ID IAEG000001 1327-53-3 215-481-4 Diarsenic trioxide Arsenic trioxide R1;R2;D1 2015-03-17 2015-03-17 100.014.075 Substance Direct Entry IAEG000002 1303-28-2 215-116-9 Diarsenic pentaoxide Arsenic pentoxide; Arsenic oxide R1;R2;D1 2015-03-17 2015-03-17 100.013.743 Substance Direct Entry IAEG000003 15606-95-8 427-700-2 Triethyl arsenate R1;R2;D1 2015-03-17 2017-08-14 100.102.611 Substance Direct Entry IAEG000004 7778-39-4 231-901-9 Arsenic acid R1;R2;D1 2015-03-17 2015-03-17 100.029.001 Substance Direct Entry IAEG000005 3687-31-8 222-979-5 Trilead diarsenate R1;R2;D1 2015-03-17 2017-08-14 100.020.890 Substance Direct Entry IAEG000006 7778-44-1 231-904-5 Calcium arsenate R1;R2;D1 2015-03-17 2017-08-14 100.029.003 Substance Direct Entry IAEG000009 12006-15-4 234-484-1 Cadmium arsenide Tricadmium diarsenide R1;R2;D1 2017-08-14 2017-08-14 Substance Direct Entry IAEG000021 7440-41-7 231-150-7 Beryllium (Be) R2 2015-03-17 2019-01-24 Substance Direct Entry IAEG000022 1306-19-0 215-146-2 Cadmium oxide R1;R2;D1 2015-03-17 2017-08-14 100.013.770 Substance Direct Entry IAEG000023 10108-64-2 233-296-7 Cadmium
    [Show full text]
  • Novel Architectures in Cavitand Chemistry: Shaping Molecular Inner Space
    Novel Architectures in Cavitand Chemistry: Shaping Molecular Inner Space DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Keith Robert Hermann Graduate Program in Chemistry The Ohio State University 2014 Dissertation Committee: Professor Jovica D. Badjić, Advisor Professor T.V. RajanBabu Professor Psaras L. McGrier Copyright by Keith Robert Hermann 2014 Abstract As long as chemists have marveled at the specificity of interactions in enzymes, nucleic acids, and other biological motifs that contain an inner cavity, there has been much desire to construct molecules that mimic these in function. Inspired by work performed by Charles J. Pederson on crown ethers, Donald J. Cram conducted seminal research into the construction and the host-guest interactions of a number of molecular architectures, specifically with his work on carcerands and hemicarcerands. Since Cram’s early work, the field of cavitand chemistry has taken off, providing endless examples in architecture capable of enclosing the space around a guest molecule. Some common examples of artificial hosts are cryptophanes, cucurbit[n]urils, and calixaranes. Function and application vary as much as structure, and range from stabilizing reactive intermediates and probing fundamental questions in physical organic chemistry, to drug delivery and chiral separations. Meanwhile, in the Badjić Group, the development of cavitands functionalized with dynamic apertures, or gates, has allowed us to probe fundamental questions in the kinetics of encapsulation. These studies, however, have relied upon a single C3v symmetric host. As a result, the group has taken on the challenge of constructing new architectures giving consideration toward the inner space geometry to allow for installation of “gate” moieties onto these architectures.
    [Show full text]
  • Essentials of Heterocyclic Chemistry-I Heterocyclic Chemistry
    Baran, Richter Essentials of Heterocyclic Chemistry-I Heterocyclic Chemistry 5 4 Deprotonation of N–H, Deprotonation of C–H, Deprotonation of Conjugate Acid 3 4 3 4 5 4 3 5 6 6 3 3 4 6 2 2 N 4 4 3 4 3 4 3 3 5 5 2 3 5 4 N HN 5 2 N N 7 2 7 N N 5 2 5 2 7 2 2 1 1 N NH H H 8 1 8 N 6 4 N 5 1 2 6 3 4 N 1 6 3 1 8 N 2-Pyrazoline Pyrazolidine H N 9 1 1 5 N 1 Quinazoline N 7 7 H Cinnoline 1 Pyrrolidine H 2 5 2 5 4 5 4 4 Isoindole 3H-Indole 6 Pyrazole N 3 4 Pyrimidine N pK : 11.3,44 Carbazole N 1 6 6 3 N 3 5 1 a N N 3 5 H 4 7 H pKa: 19.8, 35.9 N N pKa: 1.3 pKa: 19.9 8 3 Pyrrole 1 5 7 2 7 N 2 3 4 3 4 3 4 7 Indole 2 N 6 2 6 2 N N pK : 23.0, 39.5 2 8 1 8 1 N N a 6 pKa: 21.0, 38.1 1 1 2 5 2 5 2 5 6 N N 1 4 Pteridine 4 4 7 Phthalazine 1,2,4-Triazine 1,3,5-Triazine N 1 N 1 N 1 5 3 H N H H 3 5 pK : <0 pK : <0 3 5 Indoline H a a 3-Pyrroline 2H-Pyrrole 2-Pyrroline Indolizine 4 5 4 4 pKa: 4.9 2 6 N N 4 5 6 3 N 6 N 3 5 6 3 N 5 2 N 1 3 7 2 1 4 4 3 4 3 4 3 4 3 3 N 4 4 2 6 5 5 5 Pyrazine 7 2 6 Pyridazine 2 3 5 3 5 N 2 8 N 1 2 2 1 8 N 2 5 O 2 5 pKa: 0.6 H 1 1 N10 9 7 H pKa: 2.3 O 6 6 2 6 2 6 6 S Piperazine 1 O 1 O S 1 1 Quinoxaline 1H-Indazole 7 7 1 1 O1 7 Phenazine Furan Thiophene Benzofuran Isobenzofuran 2H-Pyran 4H-Pyran Benzo[b]thiophene Effects of Substitution on Pyridine Basicity: pKa: 35.6 pKa: 33.0 pKa: 33.2 pKa: 32.4 t 4 Me Bu NH2 NHAc OMe SMe Cl Ph vinyl CN NO2 CH(OH)2 4 8 5 4 9 1 3 2-position 6.0 5.8 6.9 4.1 3.3 3.6 0.7 4.5 4.8 –0.3 –2.6 3.8 6 3 3 5 7 4 8 2 3 5 2 3-position 5.7 5.9 6.1 4.5 4.9 4.4 2.8 4.8 4.8 1.4 0.6 3.8 4 2 6 7 7 3 N2 N 1 4-position
    [Show full text]
  • IUPAC Nomenclature of Fused and Bridged Fused Ring Systems
    Pure &App/. Chern., Vol. 70, No. 1, pp. 143-216, 1998. Printed in Great Britain. Q 1998 IUPAC INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY ORGANIC CHEMISTRY DIVISION COMMISSION ON NOMENCLATURE OF ORGANIC CHEMISTRY (111.1) NOMENCLATURE OF FUSED AND BRIDGED FUSED RING SYSTEMS (IUPAC Recommendations 1998) Prepared for publication by G. P. MOSS Department of Chemistry, Queen Mary and Westfield College, Mile End Road, London, El 4NS, UK Membership of the Working Party (1982-1997): A. T. Balaban (Romania), A. J. Boulton (UK), P. M. Giles, Jr. (USA), E. W. Godly (UK), H. Gutmann (Switzerland), A. K. Ikizler (Turkey), M. V. Kisakiirek (Switzerland), S. P. Klesney (USA), N. Lozac’h (France), A. D. McNaught (UK), G. P. Moss (UK), J. Nyitrai (Hungary), W. H. Powell (USA), Ch. Schmitz (France), 0. Weissbach (Federal Republic of Germany) Membership of the Commission on Nomenclature of Organic Chemistry during the preparation of this document was as follows: Titular Members: 0. Achmatowicz (Poland) 1979-1987; J. Blackwood (USA) 1996; H. J. T. Bos (Netherlands) 1987-1995, Vice-chairman, 1991- ; J. R. Bull (Republic of South Africa) 1987-1993; F. Cozzi (Italy) 1996- ; H. A. Favre (Canada) 1989-, Chairman, 1991- ; P. M. Giles, Jr. (USA) 1989-1995; E. W. Godly (UK) 1987-1993, Secretary, 1989-1993; D. Hellwinkel (Federal Republic of Germany) 1979-1987, Vice-Chainnan, 1981-1987; B. J. Herold (Portugal) 1994- ; K. Hirayama (Japan) 1975-1983; M. V. Kisakiirek (Switzerland) 1994, Vice-chairman, 1996- ; A. D. McNaught (UK) 1979-1987; G. P. Moss (UK) 1977-1987, Chairman, 1981-1987, Vice-chairman, 1979-1981; R.
    [Show full text]
  • Dr. James H. Reeves Dr. Pamela J. Seaton Dr. Paulo F. Almeida Dr
    COMPUTED NMR SHIELDING VALUES OF UNSATURATED FIVE-MEMBERED- HETEROCYCLIC RING COMPOUNDS AND THEIR BENZO-ANALOGS AS A MEASURE OF AROMATICITY Eddie LaReece Pittman A Thesis Submitted to the University of North Carolina Wilmington in Partial Fulfillment of the Requirements for the Degree of Master of Science Department of Chemistry and Biochemistry University of North Carolina Wilmington 2008 Approved by Advisory Committee ______________________________Dr. James H. Reeves ______________________________ Dr. Pamela J. Seaton ______________________________ Dr. Paulo F. Almeida ______________________________ Dr. Ned H. Martin Chair Accepted by ______________________________ Dean, Graduate School TABLE OF CONTENTS ABSTRACT....................................................................................................................... iv ACKNOWLEDGEMENTS................................................................................................ v LIST OF TABLES...........................................................................................................viii LIST OF FIGURES ........................................................................................................... ix 1. INTRODUCTION .......................................................................................................... 1 2. OBJECTIVE ................................................................................................................... 8 3. EXPERIMENTAL METHODS...................................................................................
    [Show full text]
  • Imidazo[1,2-A]Pyrazine Compounds for Treatment of Viral Infections Such As Hepatitis
    (19) TZZ Z T (11) EP 2 567 960 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 13.03.2013 Bulletin 2013/11 C07D 487/04 (2006.01) A61K 31/4985 (2006.01) A61P 31/00 (2006.01) (21) Application number: 12188861.4 (22) Date of filing: 20.08.2008 (84) Designated Contracting States: • Palmer, Nicholas John AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Saffron Walden HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT Essex CB10 1XL (GB) RO SE SI SK TR • Parsy, Christophe Claude 34830 Jacou (FR) (30) Priority: 21.08.2007 GB 0716292 • Goldsmith, Michael Daniel Saffron Walden (62) Document number(s) of the earlier application(s) in Essex CB10 1XL (GB) accordance with Art. 76 EPC: • Harris, Clifford John 08787346.9 / 2 193 131 Eynsford Kent DA4 0AB (GB) (27) Previously filed application: 20.08.2008 EP 08787346 (74) Representative: Turkalj, Gordana Galapagos istrazivacki centar d.o.o. (71) Applicant: Biofocus DPI Limited Intellectual Property Walden, Essex CB10 1XL (GB) Prilaz baruna Filipovica 29 10000 Zagreb (HR) (72) Inventors: • Macleod, Angus Remarks: Saffron Walden •This application was filed on 17-10-2012 as a Essex CB10 1XL (GB) divisional application to the application mentioned • Mitchell, Dale Robert under INID code 62. Saffron Walden •Claims (16-51)+(54-57) are deemed to be Essex CB10 1XL (GB) abandoned due to non-payment of the claims fees (Rule 45(3) EPC). (54) Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis (57) Novel imidazopyrazine compounds are dis- The compounds may be prepared as pharmaceuti- closed that have a formula represented by the following: cal compositions, and may be used for the prevention and treatment of a viral infection, in particular a HCV, HRV, Sb and/or CVB in a patient in need thereof.
    [Show full text]
  • Tetrabutylammonium Bromide (TBAB) Catalyzed Synthesis of Bioactive Heterocycles
    molecules Review Tetrabutylammonium Bromide (TBAB) Catalyzed Synthesis of Bioactive Heterocycles Bimal Krishna Banik 1,*, Bubun Banerjee 2 , Gurpreet Kaur 2, Shivam Saroch 2 and Rajat Kumar 2 1 Department of Mathematics and Natural Sciences, College of Sciences and Human Studies, Deanship of Research Development, Prince Mohammad Bin Fahd University, Al Khobar 31952, Saudi Arabia 2 Department of Chemistry, Indus International University, V.P.O. Bathu, Distt. Una, Himachal Pradesh 174301, India; [email protected] or [email protected] (B.B.); [email protected] (G.K.); [email protected] (S.S.); [email protected] (R.K.) * Correspondence: [email protected] or [email protected] Academic Editors: Toshifumi Dohi, Cheng-Pan Zhang and György Keglevich Received: 25 August 2020; Accepted: 23 September 2020; Published: 14 December 2020 Abstract: During the last two decades, tetrabutylammonium bromide (TBAB) has gained significant attention as an efficient metal-free homogeneous phase-transfer catalyst. A catalytic amount of TBAB is sufficient to catalyze various alkylation, oxidation, reduction, and esterification processes. It is also employed as an efficient co-catalyst for numerous coupling reactions. It has also acted as an efficient zwitterionic solvent in many organic transformations under molten conditions. In this review, we have summarized the recent developments on TBAB-catalyzed protocols for the efficient synthesis of various biologically promising heterocyclic scaffolds. Keywords: tetrabutylammonium bromide; TBAB; phase-transfer
    [Show full text]
  • Imidazo[1,2-A]Pyrazine Compounds for Treatment
    (19) TZZ _¥_¥__T (11) EP 2 193 131 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07D 487/04 (2006.01) A61K 31/4985 (2006.01) 30.01.2013 Bulletin 2013/05 A61P 31/00 (2006.01) (21) Application number: 08787346.9 (86) International application number: PCT/EP2008/060896 (22) Date of filing: 20.08.2008 (87) International publication number: WO 2009/024585 (26.02.2009 Gazette 2009/09) (54) IMIDAZO[1,2-A]PYRAZINE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS SUCH AS HEPATITIS IMIDAZO[1,2-A]PYRAZINVERBINDUNGEN ZUR BEHANDLUNG VON VIRUSINFEKTIONEN WIE HEPATITIS Composés d’imidazo[1,2-a]pyrazine pour le traitement d’infections virales comme l’hépatite (84) Designated Contracting States: • HARRIS, Clifford John AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Eynsford HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT Kent DA4 0AB (GB) RO SE SI SK TR (74) Representative: Nichol, Maria Zenarosa (30) Priority: 21.08.2007 GB 0716292 Galapagos NV Chesterford Research Park (43) Date of publication of application: Saffron Walden, Essex CB10 1XL (GB) 09.06.2010 Bulletin 2010/23 (56) References cited: (60) Divisional application: WO-A-02/060492 WO-A-2007/058942 12188861.4 WO-A-2008/030795 WO-A-2008/079460 US-A1- 2004 063 715 US-A1- 2004 220 189 (73) Proprietor: Biofocus DPI Limited US-A1- 2005 009 832 US-A1- 2007 105 864 Walden, Essex CB10 1XL (GB) • BONNET P A ET AL: "Synthesis and (72) Inventors: antibronchospastic activity of 8-alkoxy- and • MACLEOD, Angus 8-(alkylamino)imidazo(1,2-a)pyrazines" Saffron JOURNAL OF MEDICINAL CHEMISTRY, US Walden, Essex CB10 1XL (GB) AMERICAN CHEMICAL SOCIETY.
    [Show full text]
  • Reversible Thermochromic Composition
    ^ ^ ^ ^ I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ I ^ (1 9) European Patent Office Office europeen des brevets EP 0 908 501 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) |nt CI* C09K 9/02, B41 M 5/28 14.04.1999 Bulletin 1999/15 (21) Application number: 98308072.2 (22) Date of filing: 05.10.1998 (84) Designated Contracting States: (72) Inventors: AT BE CH CY DE DK ES Fl FR GB GR IE IT LI LU • Shibahashi, Yutaka MC NL PT SE Nagoya-shi, Aichi-ken (JP) Designated Extension States: • Sugai, Jun AL LT LV MK RO SI Nagoya-shi, Aichi-ken (JP) (30) Priority: 07.10.1997 J P 291630/97 (74) Representative: West, Alan Harry et al R.G.C. Jenkins & Co. (71) Applicant: THE PILOT INK CO., LTD. 26 Caxton Street Nagoya-shi, Aichi-ken (JP) London SW1 H 0RH (GB) (54) Reversible thermochromic composition (57) A reversible thermochromic composition is pro- exchange reaction between the components and re- vided which contains a specified diazarhodamine lac- versibly at a specified temperature range. This reversi- tone derivative as an electron-donating color-develop- ble thermochromic composition develops clear reddish ing organic compound, an electron-accepting com- color at a colored state, and becomes colorless at a de- pound, and a reaction medium for causing an electron colored state without residual color. < O lO 00 o O) o a. LU Printed by Jouve, 75001 PARIS (FR) EP 0 908 501 A1 Description [0001] The present invention relates to a reversible thermochromic composition. Specifically, the present invention relates to a reversible thermochromic composition which develops a clear color in red hue, especially a vivid pink color 5 in a colored state, and becomes colorless in a decolored state.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20120319052A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2012/0319052 A1 Brocke et al. (43) Pub. Date: Dec. 20, 2012 (54) COMPOUNDS FOR ELECTRONIC DEVICES Publication Classi?cation (75) Inventors: Constanze Brocke, Gross-Gerau (DE); (51) Int. Cl. Christof P?umm, Darmstatd (DE); H01 B 1/12 (2006.01) Amir Hossain Parham, Frankfurt am C07D 513/00 (200601) Main (DE); Rocco Fortte, Frankfurt am C08G 73/06 (200601) Main (DE) C07D 401/10 (2006.01) . _ (52) US. Cl. .......... .. 252/500; 546/102; 546/58; 546/38; (73) Asslgnee. Merck Patent GmbH, Darmstadt (DE) 544/14; 526/259; 526/257 (21) Appl. N0.: 13/581,543 (22) PCT Filed: Jan. 21, 2011 (57) ABSTRACT (86) PCT N0.: PCT/EP2011/000235 The present invention relates to compounds of the formula (1) (2)’§371(c)(1), (4) Date: Aug 28, 2012 or ( 2 ) d to h e use h ereo f.in'e 1 ectronic. devices, . an d to electromc devices Wh1ch comprise these compounds. The (30) Foreign Application Priority Data invention furthermore relates to the preparation of the com pounds of the formula (1) or (2) and to formulations compris Mar. 2, 2010 (DE) .................... .. 10 2010 009 903.1 ing one or more compounds of the formula (1) or (2). US 2012/0319052 A1 Dec. 20, 2012 COMPOUNDS FOR ELECTRONIC DEVICES materials in electronic devices. In the triarylamine com pounds, the individual aryl groups are bridged to one another [0001] The present invention relates to compounds of the formula (1) or (2) and to the use thereof in electronic devices, in a de?ned manner and are additionally substituted by car and to electronic devices Which comprise these compounds.
    [Show full text]